Companies
Hx

Healx

AI-powered drug repurposing for rare diseases

Founded2014
HQCambridge, UK
StagePreclinical
healx.io
SharePostShare

Overview

Healx uses AI to discover new treatments for rare diseases by repurposing existing drugs. The company's Healnet platform combines knowledge graphs, network pharmacology, and machine learning to identify novel drug-disease connections across hundreds of rare diseases. By focusing on drugs with established safety profiles, Healx aims to dramatically reduce the time and cost of bringing treatments to underserved patient populations.

Focus areas

Target Discovery, Virtual Screening, Platform

Key models

Healnet

500+ rare diseases analyzed


Technology

Healnet AI platform integrates biomedical knowledge graphs, network pharmacology, and machine learning to identify drug repurposing opportunities for rare diseases. The platform has analyzed over 500 rare diseases to find novel therapeutic connections using existing approved or clinical-stage drugs.

Platforms & Tools
HealnetKnowledge graphNetwork pharmacologyDrug repurposing engine

Leadership

Tim Guilliams

CEO & Co-Founder

PhD from University of Cambridge


Similar companies

Get updates on Healx

We'll notify you when we publish updates about Healx.